Management of Chemical and Biological Samples for Screening Applications
, by Wigglesworth, Mark; Wood, Terry- ISBN: 9783527328222 | 352732822X
- Cover: Hardcover
- Copyright: 4/30/2012
Now a freelance business consultant, Terry Wood retired in 2011 as the manager of the Liquid Store Centre of Emphasis at Pfizer?s world-wide R&D department, based in Sandwich (UK). He has been involved in the high-throughput screening process for the whole of his 25 year career with Pfizer. This has given him a first hand and broad knowledge about the challenges and caveats of assay design, development and
prosecution. His prime responsibility focused on the management of Pfizer?s extensive compound file, using a range of automated systems for sample preparation, storage and delivery.
List of Contributors XXIII
1 Introduction to Sample Management 1
William P. Janzen and Andy Zaayenga
References 6
2 Generating a High-Quality Compound Collection 9
Philip B. Cox and Anil Vasudevan
2.1 Defining Current Screening Collections 9
2.2 Design Criteria for Enriching a Compound Collection with Drug-Like Compounds 10
2.3 Concluding Remarks 20
References 20
3 Assessing Compound Quality 23
Ioana Popa-Burke, Stephen Besley, and Zoe Blaxill
3.1 Introduction 23
3.2 Process Quality and Analytical Quality in Compound Management 24
3.3 Identity 28
3.4 Purity/Stability 32
3.5 Concentration/Solubility 39
3.6 Conclusions 41
Acknowledgments 41
References 42
Further Reading 44
4 Delivering and Maintaining Quality within Compound Management 45
Isabel Charles
4.1 Introduction 45
4.2 What is Quality from a Compound Management Perspective? 46
4.3 Storage and Delivery of Samples in Solution 47
4.4 Intercepting Low Purity 49
4.5 Storage and Delivery of Solids 51
4.6 Automation Quality Control and Reliability 52
4.7 High-Quality Data Management 54
4.8 Conclusion 55
Acknowledgments 56
References 56
5 Obtaining and Maintaining High-Quality Tissue Samples: Scientific and Technical Considerations to Promote Evidence-Based Biobanking Practice (EBBP) 59
Lisa B. Miranda
5.1 Introduction 59
5.2 The Path toward Integration of Evidence-based Biobanking Practice 62
5.3 Integrating Evidence-based Biobanking Practice into Sample Protocols 66
5.4 Final Thoughts and Recommendations 74
References 79
6 Thinking Lean in Compound Management Laboratories 83
Michael Allen
6.1 The Emergence of ‘Lean Thinking’ 83
6.2 The Application of ‘Lean Thinking’ 83
6.3 Lean Thinking in Drug Discovery 86
6.4 A Lean Laboratory Toolbox 87
6.5 Streamlining Compound Processing –An Example 101
6.6 Summary 103
References 105
7 Application of Supply Management Principles in Sample Management 107
Paul A. Gosnell
7.1 Introduction 107
7.2 Common Pitfalls of Sample Management 107
7.2.1 One Size Does Not Fit All 108
7.3 Sample Management and Supply Chain Concepts 108
7.4 Implementing the Sample Management Strategy 111
7.5 Sample Management Organization 111
7.6 Sample Management Informatics 113
7.7 Avoid Monolithic Silos of Excellence 114
7.8 Position and Synchronize Inventory 115
7.9 Expand the Sample Management Boundary 117
7.10 Measuring and Assessing Effectiveness and Quality 118
7.11 Conclusions 119
References 120
8 Solid Sample Weighing and Distribution 121
Michael Gray and Snehal Bhatt
8.1 The Practicalities and Technology of Weighing Solid Compounds 121
8.2 Logistical Challenges of Transportation of Small Molecules 127
References 142
9 Managing a Global Biological Resource of Cells and Cellular Derivatives 143
Frank P. Simione and Raymond H. Cypess
9.1 Introduction 143
9.2 Diversity of Collections 144
9.3 Sourcing and Acquisition 148
9.4 Authentication and Characterization 149
9.5 Cryopreservation, Storage, and Production 153
9.6 Data Management 154
9.7 Quality and Standards 155
9.8 Order Fulfillment and Distribution 157
9.9 Offsite Biorepository Management 158
9.10 Regulatory and Legal Compliance 159
9.11 Ownership and Intellectual Property Management 160
9.12 Collaborations 161
9.13 Conclusion 162
References 163
10 Development of Automation in Sample Management 165
Gregory J. Wendel
10.1 Introduction 165
10.2 Historical Background 165
10.3 Automation of Sample Management Today 167
10.4 System Building Blocks 169
10.5 Storage Systems 171
10.6 Liquid Handler 175
10.7 Accessories 180
10.8 Plate Handling, Integration 184
10.9 Case Study: Evolution of a Compound Management Group 186
10.10 Results 196
References 197
11 Applications of Acoustic Technology 199
Eric Tang, Colin Bath, and Sue Holland-Crimmin
11.1 Introduction 199
11.2 Compound-Handling Challenges in Drug Discovery 201
11.3 Acoustic Drop Ejection –Performance, Quality Assurance, and Platform Validation 203
11.4 Acoustic-Assisted Compound Solubilization and Mixing 206
11.5 Acoustic Applications in Drug Discovery 209
11.6 Emerging Applications 216
References 218
12 Enhancing Biorepository Sample Integrity with Automated Storage and Retrieval 221
Johann van Niekerk
12.1 The Emerging Growth of Biobanking 221
12.2 Automated Storage and Retrieval in a Biorepository 225
12.3 Configuration of an Automated Biorepository 236
12.4 Conclusions 241
References 241
13 Information Technology Systems for Sample Management 243
Brian Brooks
13.1 Sample Registration 243
13.2 Intellectual Property and Laboratory Notebooks 253
13.3 Some Observations on Information Technology 254
13.4 Biological Data Management 255
Dedication and Acknowledgments 263
14 Key Features of a Compound Management System 265
Clive Battle
14.1 Why Do We Need Compound Management Information Technology Systems? 265
14.2 Compound Management Software 266
14.3 Benefits of Commercially Available Compound Management Systems 272
References 273
15 What Does an HTS File of the Future Look Like? 275
François Bertelli
15.1 Introduction 275
15.2 History of Compounds Collection for HTS 276
15.3 Impact of High-Throughput Chemistry on Corporate Files 277
15.4 Chemical Library Management 278
15.5 The Concept of Drug-Likeness and the Lipinski Rules 279
15.6 Quality versus Quantity 283
15.7 The Emergence of the Subsets: Fragment, G-Protein-Coupled Receptor (GPCR), Ion Channel, Kinase, Protein–Protein Interaction, Chemogenomics, Library Of Pharmacologically Active Compounds (LOPAC), Central Nervous System (CNS), and Diversity 285
15.8 Re-designing the Corporate File for the Future 291
15.9 Future Routes for Hit Identification 299
References 301
16 New Enabling Technology 305
Neil Hardy, Ji Yi Khoo, Shoufeng Yang, Holger Eickhoff, Joe Olechno, and Richard Ellson
16.1 Introduction 305
16.2 A Drop-On-Demand Printer for Dry Powder Dispensing 307
16.3 Piezo Dispense Pens: Integrated Storage and Dispensing Devices and their Potential in Secondary Screening and Diagnostic Manufacturing 312
16.4 Future Directions in Acoustic Droplet Ejection Technology 323
16.5 Closing Remarks 347
References 347
17 The Impact of Future Technologies within Biobanking 351
Manuel M. Morente, Laura Cereceda, and Mar´ıa J. Artiga
17.1 Introduction 351
17.2 The Role of Biobanks in Biomedical Research 351
17.3 The Increasing Complexity of Biobanking 354
17.4 Future Technologies and Biobanking: How Could New Technologies Affect the Daily Activities of Biobanks? 356
17.5 The Future of Biobanking Does Not Depend on Technological Developments Alone 363
17.6 Conclusions 364
Acknowledgments 364
References 364
18 Outsourcing Sample Management 367
Sylviane Boucharens and Amelia Wall Warner
18.1 Outsourcing in the Pharmaceutical Industry 367
18.2 Outsourcing Biological Specimen Collections 374
18.3 Conclusions 378
Acknowledgments 378
References 378
19 Sample Management Yesterday and Tomorrow 381
Terry Wood and Mark Wigglesworth
19.1 The Role of Sample Management 381
19.2 Automation of Compound Management 382
19.3 Compound Integrity 384
19.4 Reduction of Redundancy 386
19.5 The Future of Sample Management? 387
19.6 Concluding Remarks 390
References 391
Index 393
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.